Apathy and anhedonia rating scales in Parkinson's disease: critique and recommendations

Movement Disorders : Official Journal of the Movement Disorder Society
A LeentjensChristopher G Goetz

Abstract

Apathy is a common condition in Parkinson's disease (PD) and is generally defined as a lack of motivation. It is associated with more severe cognitive dysfunction and a decrease in activities of daily living (ADL) performance. Anhedonia, the inability to experience pleasure, can be a symptom of both depressive and apathetic syndromes. The Movement Disorder Society (MDS) commissioned a task force to assess the clinimetric properties of apathy and anhedonia scales in PD patients. A systematic literature review was conducted to identify scales that have either been validated or used in PD patients. Apathy scales identified for review include the Apathy Evaluation Scale (AES), the Apathy Scale (AS), the Apathy Inventory (AI), and the Lille Apathy Rating Scale (LARS). In addition, item 4 (motivation/initiative) of the Unified Parkinson's Disease Rating Scale (UPDRS) and item 7 (apathy) of the Neuropsychiatric Inventory (NPI) were included. Anhedonia scales identified for review were the Snaith-Hamilton Pleasure Scale (SHAPS) and the Chapman scales for physical and social anhedonia. Only the AS is classified as "recommended" to assess apathy in PD. Although item 4 of the UPDRS also meets the criteria to be classified as recommended, ...Continue Reading

References

Aug 1, 1976·Journal of Abnormal Psychology·L J ChapmanM L Raulin
Jan 1, 1992·The Journal of Neuropsychiatry and Clinical Neurosciences·S E StarksteinR G Robinson
Aug 1, 1991·Psychiatry Research·R S MarinS Firinciogullari
Jan 1, 1991·The Journal of Neuropsychiatry and Clinical Neurosciences·R S Marin
Jul 1, 1995·The British Journal of Psychiatry : the Journal of Mental Science·R P SnaithP Trigwell
Aug 26, 1998·The Journal of Neuropsychiatry and Clinical Neurosciences·M L LevyI Litvan
Sep 16, 1999·Journal of Neurology, Neurosurgery, and Psychiatry·D AarslandJ L Cummings
Mar 1, 1996·History of Psychiatry·G E Berrios
Mar 29, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·Valeria IsellaIldebrando Appollonio
Sep 24, 2002·Der Nervenarzt·H ReichmannM R Lemke
Nov 12, 2002·The Journal of Neuropsychiatry and Clinical Neurosciences·Anjan Chatterjee, Stanley Fahn
Nov 20, 2002·Journal of Neurology, Neurosurgery, and Psychiatry·G C Pluck, R G Brown
Aug 23, 2003·Journal of Neurology, Neurosurgery, and Psychiatry·V IsellaM Grimaldi
Jun 9, 2005·The Journal of Neuropsychiatry and Clinical Neurosciences·Matthias R LemkeHeinz Reichmann
Jul 19, 2005·Journal of Neurology, Neurosurgery, and Psychiatry·S E StarksteinR Mizrahi
Oct 8, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Laura MarshUNKNOWN NINDS/NIMH Work Group on Depression and Parkinson's Disease
Apr 12, 2006·Journal of Neurology·D DrapierB Millet
Apr 15, 2006·Journal of Neurology, Neurosurgery, and Psychiatry·P SockeelL Defebvre
Jul 4, 2006·Journal of the Neurological Sciences·Matthias R LemkeHeinz Reichmann
Jul 13, 2006·Neurology·L Kirsch-DarrowD Bowers
Sep 12, 2006·The Journal of Neuropsychiatry and Clinical Neurosciences·Karsten WittPaul Krack
Nov 23, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Christopher G GoetzNancy LaPelle
Feb 10, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Kathy DujardinLuc Defebvre
Feb 20, 2007·The Journal of Neuropsychiatry and Clinical Neurosciences·Diana E ClarkeDavid Conn
Feb 20, 2007·The Journal of Neuropsychiatry and Clinical Neurosciences·Prasad R PadalaFrederick Petty
Mar 31, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Anette SchragChristopher G Goetz
Aug 28, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Sergio E Starkstein, Marcelo Merello
Dec 13, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Sergio E StarksteinRobert G Robinson
Jan 5, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Hubert H FernandezChristopher G Goetz

❮ Previous
Next ❯

Citations

Aug 26, 2009·Journal of Neurology·Kenn Freddy PedersenJan Petter Larsen
Apr 25, 2012·Journal of Neurology·Pablo Martinez-MartinAngel Ayuga-Martinez
Mar 2, 2011·Current Treatment Options in Neurology·Sergio E Starkstein, Simone Brockman
May 18, 2010·Neurotoxicity Research·Thomas N Chase
Nov 21, 2013·Clinical Neurology and Neurosurgery·Kiyohiro MatsuiNobuyuki Oka
Nov 2, 2011·Journal of the International Neuropsychological Society : JINS·Lindsey Kirsch-DarrowDawn Bowers
Mar 15, 2011·Social Neuroscience·Andrew D LawrenceDavid J Brooks
Dec 29, 2011·Parkinson's Disease·Yelena Bogdanova, Alice Cronin-Golomb
Jan 13, 2012·Neuroepidemiology·Esther CuboUNKNOWN ANIMO Study Group
Aug 4, 2012·Journal of Geriatric Psychiatry and Neurology·Laura B ZahodneDawn Bowers
Oct 27, 2010·Parkinson's Disease·Mercè Martínez-CorralJaime Kulisevsky
Jun 14, 2012·Current Gerontology and Geriatrics Research·Progress Njomboro, Shoumitro Deb
Jul 26, 2012·Current Gerontology and Geriatrics Research·David J AhearnIracema Leroi
Sep 15, 2012·European Journal of Nuclear Medicine and Molecular Imaging·Daniela Di GiudaAlfonso Fasano
Dec 7, 2013·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Mayela Rodríguez-ViolanteAzyadeh Camacho-Ordoñez
Aug 8, 2013·Neuropsychology Review·Annabelle ArnouldMartial Van der Linden
Jun 27, 2014·Journal of the International Neuropsychological Society : JINS·Alberto CostaGiovanni Augusto Carlesimo
Nov 18, 2014·Parkinson's Disease·Mayela Rodríguez-ViolantePablo Martinez-Martin
Jul 10, 2010·The International Journal of Neuroscience·Philip O BuckJamie Clark
Mar 1, 2016·Parkinson's Disease·Monika Gołąb-JanowskaKrystyna Honczarenko
Apr 30, 2013·Journal of Neuropsychology·Nihal SinhaMasud Husain
Aug 1, 2015·Parkinsonism & Related Disorders·Graham D CochraneJoseph H Friedman
Sep 13, 2012·Parkinson's Disease·Iracema LeroiVijay Harbishettar
Apr 9, 2015·Frontiers in Human Neuroscience·Francesco AngelucciAlberto Costa
Nov 26, 2013·Cortex; a Journal Devoted to the Study of the Nervous System and Behavior·Omer PoratRachel Tomer
Feb 3, 2015·Frontiers in Aging Neuroscience·Antonia MeyerPeter Fuhr
Mar 22, 2014·Frontiers in Neurology·Gwenolé LoasPierre Krystkowiak
Jun 9, 2016·Journal of Clinical and Experimental Neuropsychology·Whitney FittsNabila Dahodwala
Jul 5, 2016·Neuroscience and Biobehavioral Reviews·Tetsuya AsakawaYing Xia
Aug 6, 2016·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration·Tanja StojkovicZorica Stevic

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Movement Disorders : Official Journal of the Movement Disorder Society
K DujardinLuc Defebvre
Journal of Neurology, Neurosurgery, and Psychiatry
G C Pluck, R G Brown
Movement Disorders : Official Journal of the Movement Disorder Society
S E StarksteinBrian Power
European Psychiatry : the Journal of the Association of European Psychiatrists
P H RobertJ Byrne
© 2022 Meta ULC. All rights reserved